TABLE 1.
Factor | Values for indicated subject malaria exposure condition |
P value | |
---|---|---|---|
Exposed | Unexposed | ||
Maternal characteristics | |||
n | 44 (63) | 26 (37) | 0.041 |
Age, yr (mean) [SD] | 22.36 [± 6.10] | 21.77 [± 6.79] | 0.566 |
<20 yr | 18 (41) | 12 (46) | 0.790 |
>20 yr | 26 (59) | 14 (54) | 0.763 |
Gestational age | |||
<37 wks | 8 (18) | 4 (15) | 0.900 |
>37 wks | 33 (75) | 18 (69) | 0.648 |
Gravida | |||
Primigravida | 16 (36) | 7 (30) | 0.784 |
Secundigravida | 12 (28) | 12 (40) | 0.548 |
Multigravida | 16 (36) | 7 (30) | 0.784 |
TT vaccine (current pregnancy) | 42 (95) | 24 (92) | 0.627 |
Bed net use | 32 (73) | 20 (77) | 0.750 |
EBV seroprevalence (%) | 44 (100) | 26 (100) | 1.000 |
Mean total IgG [SD] (mg/ml) | 29.15 [± 10.12] | 25.29 [± 8.93] | 0.112 |
Neonate characteristics | |||
Mean birth wt (g) [SD] | 3,171 [± 444] | 3,146 [± 420] | 0.923 |
Time of malaria exposure | |||
Early | 31 (70) | ||
Late | 13 (30) |
Data are presented as number (percent) unless otherwise stated. Differences in proportions between the groups were determined by the Fisher exact test. Early exposure to malaria was defined as <26 weeks gestation; late exposure was defined as >26 weeks gestation.